This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Stocks Insiders Are Scooping Up

Halozyme Therapeutics

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

In the biotechnology and drugs complex, insiders are buying up a massive amount of stock in Halozyme Therapeutics (HALO - Get Report), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the diabetes, cancer, dermatology and drug delivery markets. Insiders are loading up into strength here since this stock is up over 23% so far in 2012.

Halozyme Therapeutics has a market cap of $1.21 billion and an enterprise value of $1.15 billion. This stock trades at a rich valuation, with a price-to-sales of 21.17 and a price-to-book of 44.81. Its estimated growth rate for this year is 71.4%, and for next year it's pegged at -187.5%. This is a cash-rich company, since the total cash position on its balance sheet is $66.33 million and its total debt is zero.

>>5 Biotech Stocks for 2012

A director and beneficial owner just bought 1.36 million shares, or $14.4 million worth of stock, at $10.61 per share.

From a technical perspective, HALO is currently trading above both its 50-day and 200-day moving averages, which is bullish. This stock has been uptrending strong since it hit a recent low last October at $5.60 a share. Since tagging that low, shares of HALO have been making mostly higher lows and higher highs, which is bullish price action. This stock recently broke out above some near-term overhead resistance at $11.62 a share.

If you're bullish on HALO, I would look for long biased trades as long as the stock is trending above that breakout price of $11.62. If this stock happens to pullback below the breakout price, then I would only get long near its 50-day moving average of $10.18 a share, as long as that moving average isn't violated to the downside.

2 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
NYX $0.00 0.00%
CVS $100.39 0.00%
FSYS $11.02 0.00%
HALO $15.30 0.00%
TWO $10.67 0.00%

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs